SCHEMBL21653152

SCHEMBL21653152

CCn1cc(NC(=O)c2cnc(Cl)s2)cc(F)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 2/20 0.42
▸ BACE2 Q9Y5Z0 1/20 0.42
▸ RAF1 P04049 4/20 0.37
▸ BRAF P15056 4/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ PDE10A Q9Y233 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ ABL1 P00519 2/20 0.35
▸ BCR P11274 2/20 0.35
▸ HDAC1 Q13547 2/20 0.35
▸ MAPK14 Q16539 2/20 0.35
▸ HDAC3 O15379 1/20 0.35
▸ HDAC4 P56524 1/20 0.35
▸ HDAC7 Q8WUI4 1/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ HDAC10 Q969S8 1/20 0.35
▸ HDAC11 Q96DB2 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21653259 0.89 BACE1 (0.39) BACE1BACE2RAF1BRAFKMT2A
SCHEMBL21653081 0.89 SMN1; SMN2 (0.38) BACE1BACE2RAF1BRAFKMT2A
SCHEMBL21653244 0.88 BACE1 (0.39) BACE1BACE2KMT2AABL1MAPT
SCHEMBL21652875 0.85 LRRK2 (0.39) BACE1RAF1BRAFKCNH2PDE10A
SCHEMBL21653156 0.82 PDE10A (0.38) BACE1KMT2AKCNH2PDE10ASMN1; SMN2
SCHEMBL21653229 0.81 RAB9A (0.42) BACE1BACE2KMT2ASMN1; SMN2MAPK14
SCHEMBL21653075 0.79 KMT2A (0.36) BACE1BACE2KMT2AABL1MAPT
SCHEMBL21653151 0.78 PDE10A (0.35) KMT2APDE10ASMN1; SMN2MAPTNPC1
SCHEMBL21653089 0.78 PDE10A (0.35) PDE10AMAPTTP53MAPK1
SCHEMBL21653261 0.76 LRRK2 (0.39) RAF1BRAFKMT2APDE10ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020023657-A1 PYRIDIN-2-ONE COMPOUNDS USEFUL AS SMARCA2 ANTAGONISTS Epizyme, Inc. (US) 2020-01-30 — — WO disclosed
Send feedback